BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 36790675)

  • 1. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
    Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 4. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome: New biomarkers in early screening of colorectal cancer.
    Zhou P; Yang D; Sun D; Zhou Y
    J Clin Lab Anal; 2022 May; 36(5):e24359. PubMed ID: 35312122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
    Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J
    Neoplasia; 2023 Feb; 36():100868. PubMed ID: 36566591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
    Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
    Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
    Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
    Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial markers in colorectal cancer detection and/or prognosis.
    Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
    World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
    Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
    Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
    Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
    mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.